Armistice Capital, LLC 13D and 13G filings for Ekso Bionics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 11:14 am Sale | 2026-03-31 | 13G | EKSO BIONICS HLDGS INC PAR EKSO | Armistice Capital, LLC | 187,151 4.990% | -103,995 (-35.72%) | Filing |
| 2026-02-17 9:44 pm Purchase | 2025-12-31 | 13G | EKSO BIONICS HLDGS INC PAR EKSO | Armistice Capital, LLC | 291,146 9.990% | 198,222 (+213.32%) | Filing |
| 2025-11-14 6:34 pm Sale | 2025-09-30 | 13G | EKSO BIONICS HLDGS INC PAR EKSO | Armistice Capital, LLC | 92,924 4.990% | -1,520,636 (-94.24%) | Filing |
| 2025-08-14 9:27 pm Purchase | 2025-06-30 | 13G | EKSO BIONICS HLDGS INC PAR EKSO | Armistice Capital, LLC | 1,613,560 9.990% | 1,455,659 (+921.88%) | Filing |